800 Shares in McKesson Co. (NYSE:MCK) Purchased by Moment Partners LLC

Moment Partners LLC acquired a new position in shares of McKesson Co. (NYSE:MCK - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 800 shares of the company's stock, valued at approximately $456,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Penserra Capital Management LLC grew its holdings in shares of McKesson by 21.7% in the 3rd quarter. Penserra Capital Management LLC now owns 1,075 shares of the company's stock valued at $530,000 after acquiring an additional 192 shares in the last quarter. Fisher Asset Management LLC boosted its holdings in shares of McKesson by 50.0% in the 3rd quarter. Fisher Asset Management LLC now owns 1,242 shares of the company's stock valued at $614,000 after buying an additional 414 shares during the last quarter. Independent Advisor Alliance grew its stake in shares of McKesson by 19.8% in the third quarter. Independent Advisor Alliance now owns 1,568 shares of the company's stock valued at $775,000 after buying an additional 259 shares in the last quarter. Truvestments Capital LLC bought a new stake in McKesson during the third quarter worth $60,000. Finally, FMR LLC lifted its stake in McKesson by 17.3% in the third quarter. FMR LLC now owns 2,968,239 shares of the company's stock valued at $1,467,557,000 after acquiring an additional 438,423 shares during the last quarter. 85.07% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts recently commented on the stock. Wells Fargo & Company upped their price target on shares of McKesson from $641.00 to $691.00 and gave the company an "equal weight" rating in a research note on Friday, March 14th. Morgan Stanley increased their target price on McKesson from $612.00 to $642.00 and gave the stock an "overweight" rating in a research note on Tuesday, December 17th. Citigroup dropped their price target on McKesson from $713.00 to $677.00 and set a "buy" rating for the company in a report on Friday, January 10th. Evercore ISI increased their price objective on McKesson from $650.00 to $675.00 and gave the stock an "outperform" rating in a research report on Thursday, February 6th. Finally, StockNews.com downgraded shares of McKesson from a "strong-buy" rating to a "buy" rating in a research note on Friday, February 14th. Two research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $649.36.

Remove Ads

McKesson Stock Performance

Shares of NYSE:MCK traded up $1.67 during trading on Monday, reaching $669.73. The stock had a trading volume of 229,024 shares, compared to its average volume of 814,142. The stock has a market cap of $83.93 billion, a price-to-earnings ratio of 30.69, a P/E/G ratio of 1.29 and a beta of 0.52. McKesson Co. has a 52 week low of $464.42 and a 52 week high of $678.67. The firm's fifty day moving average is $623.58 and its 200 day moving average is $579.83.

McKesson (NYSE:MCK - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $8.03 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. On average, research analysts forecast that McKesson Co. will post 32.77 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 1st. Stockholders of record on Monday, March 3rd will be paid a $0.71 dividend. The ex-dividend date is Monday, March 3rd. This represents a $2.84 annualized dividend and a dividend yield of 0.42%. McKesson's dividend payout ratio is currently 13.00%.

Insider Activity at McKesson

In other news, EVP Leann B. Smith sold 188 shares of the stock in a transaction dated Wednesday, February 12th. The shares were sold at an average price of $609.59, for a total transaction of $114,602.92. Following the transaction, the executive vice president now owns 1,051 shares of the company's stock, valued at $640,679.09. This represents a 15.17 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Brian S. Tyler sold 8,961 shares of the company's stock in a transaction that occurred on Friday, February 21st. The stock was sold at an average price of $597.99, for a total value of $5,358,588.39. Following the transaction, the chief executive officer now directly owns 60,664 shares in the company, valued at approximately $36,276,465.36. This trade represents a 12.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 18,689 shares of company stock worth $11,187,351 in the last quarter. Company insiders own 0.11% of the company's stock.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.